Published online Nov 15, 2003. doi: 10.3748/wjg.v9.i11.2505
Revised: August 1, 2003
Accepted: August 19, 2003
Published online: November 15, 2003
AIM: To investigate the effect of tetramethylpyrazine (ligustrazine, TMP) on the secretion of exocrine pancreas (and biliary).
METHODS: In in vivo study, we investigated the effect of TMP on the secretion of pancreatic-bile juice (PBJ) in rats. Using human pancreatic duct cell line, CAPAN-1, combined with the short-circuit current (ISC) technique we further studied the effect of TMP on the pancreatic anion secretion.
RESULTS: Administration of TMP (80 mg/kg, ip) significantly increased the secretion of PBJ (P < 0.05), but the pH of PBJ and the secretion of pancreatic protein were not significantly affected. Basolateral addition of TMP produced a dose-dependent increase in ISC (EC50 = 1.56 mmol/L), which contained a fast transient ISC response followed by a slow decay. Apical application of Cl- channel blockers, DPC (1 mmol/L), decreased the response by about 67.1% (P < 0.001), whereas amiloride (100 μmol/L), a epithelial sodium channel blockers, had no effect. Removal of extracellular HCO3- abolished TMP-induced increase in ISC by about 74.4% (P < 0.001), but the removal of external Cl- did not. Pretreatment with phosphodiesterase inhibitor, IBMX (0.5 mmol/L), decreased the TMP-induced ISC by 91% (P < 0.001).
CONCLUSION: TMP could stimulate the secretion of PBJ, especially pancreatic ductal HCO3- secretion via cAMP or cGMP-dependent pathway. It need further study to investigate the roles of cAMP or cGMP in the effect of TMP on the secretion of exocrine pancreas.